Les symptômes incluent des engourdissements, des troubles de l'équilibre et des problèmes de vision.
Sclérose en plaquesSymptômes neurologiques
#3
Quels signes de la maladie d'Alzheimer ?
Les signes incluent des pertes de mémoire, des difficultés de langage et des changements de comportement.
Maladie d'AlzheimerSymptômes cognitifs
#4
Quels symptômes de la maladie de Parkinson ?
Les symptômes incluent des tremblements, une rigidité musculaire et des troubles de la coordination.
Maladie de ParkinsonSymptômes moteurs
#5
Quels symptômes de l'épilepsie ?
Les symptômes incluent des convulsions, des absences et des mouvements involontaires.
ÉpilepsieConvulsions
Prévention
5
#1
Comment prévenir un AVC ?
La prévention inclut un mode de vie sain, le contrôle de la pression artérielle et l'arrêt du tabac.
Prévention de l'AVCHypertension
#2
Quelles mesures pour éviter la démence ?
Des activités cognitives, une alimentation équilibrée et l'exercice régulier peuvent aider.
Prévention de la démenceActivités cognitives
#3
Comment réduire le risque de sclérose en plaques ?
Il n'existe pas de prévention prouvée, mais un mode de vie sain peut être bénéfique.
Sclérose en plaquesMode de vie sain
#4
Quelles stratégies pour prévenir la maladie de Parkinson ?
Des études suggèrent que l'exercice régulier et une alimentation saine peuvent réduire le risque.
Maladie de ParkinsonPrévention
#5
Comment prévenir les crises d'épilepsie ?
La prise régulière de médicaments et l'évitement des déclencheurs connus sont essentiels.
ÉpilepsiePrévention des crises
Traitements
5
#1
Quels traitements pour l'AVC ischémique ?
Le traitement inclut des médicaments thrombolytiques et des interventions chirurgicales si nécessaire.
Accident vasculaire cérébralThrombolyse
#2
Comment traiter la sclérose en plaques ?
Le traitement comprend des médicaments immunomodulateurs et des thérapies symptomatiques.
Sclérose en plaquesTraitements médicamenteux
#3
Quelles options pour la maladie d'Alzheimer ?
Les options incluent des médicaments pour améliorer la mémoire et des thérapies de soutien.
Maladie d'AlzheimerTraitements cognitifs
#4
Quel traitement pour la maladie de Parkinson ?
Le traitement comprend des médicaments dopaminergiques et des thérapies physiques.
Maladie de ParkinsonTraitements médicamenteux
#5
Comment gérer l'épilepsie ?
L'épilepsie est gérée par des médicaments antiépileptiques et des interventions chirurgicales si nécessaire.
ÉpilepsieMédicaments antiépileptiques
Complications
5
#1
Quelles complications après un AVC ?
Les complications peuvent inclure des troubles de la parole, des problèmes de mobilité et des infections.
Complications de l'AVCRéhabilitation
#2
Quels risques liés à la sclérose en plaques ?
Les risques incluent des infections, des problèmes de mobilité et des troubles cognitifs.
Sclérose en plaquesComplications
#3
Quelles complications de la maladie d'Alzheimer ?
Les complications peuvent inclure des infections, des troubles de la déglutition et des chutes.
Maladie d'AlzheimerComplications
#4
Quels effets secondaires des traitements Parkinson ?
Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires.
Maladie de ParkinsonEffets secondaires
#5
Quelles complications de l'épilepsie ?
Les complications peuvent inclure des blessures dues aux crises et des problèmes psychologiques.
ÉpilepsieComplications
Facteurs de risque
5
#1
Quels facteurs de risque pour l'AVC ?
Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité.
Facteurs de risqueAccident vasculaire cérébral
#2
Quels risques pour la sclérose en plaques ?
Les facteurs de risque incluent l'âge, le sexe féminin et des antécédents familiaux.
Sclérose en plaquesFacteurs de risque
#3
Quels facteurs de risque pour la maladie d'Alzheimer ?
Les facteurs incluent l'âge avancé, des antécédents familiaux et des traumatismes crâniens.
Maladie d'AlzheimerFacteurs de risque
#4
Quels risques associés à la maladie de Parkinson ?
Les facteurs de risque incluent l'âge, des antécédents familiaux et l'exposition à des toxines.
Maladie de ParkinsonFacteurs de risque
#5
Quels facteurs de risque pour l'épilepsie ?
Les facteurs incluent des antécédents de traumatismes crâniens, des infections et des antécédents familiaux.
ÉpilepsieFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "National Institute of Neurological Disorders and Stroke (USA) : Questions médicales les plus fréquentes",
"headline": "National Institute of Neurological Disorders and Stroke (USA) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les National Institute of Neurological Disorders and Stroke (USA) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-28",
"dateModified": "2024-11-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "National Institute of Neurological Disorders and Stroke (USA)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "National Institutes of Health (USA)",
"url": "https://recherchemedicale.com/mesh/D009316",
"about": {
"@type": "MedicalCondition",
"name": "National Institutes of Health (USA)",
"code": {
"@type": "MedicalCode",
"code": "D009316",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.348.500.500.600.650.496"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "National Institute of Neurological Disorders and Stroke (USA)",
"alternateName": "National Institute of Neurological Disorders and Stroke (U.S.)",
"code": {
"@type": "MedicalCode",
"code": "D055825",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://recherchemedicale.com/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Christopher L Pin",
"url": "https://recherchemedicale.com/author/Christopher%20L%20Pin",
"affiliation": {
"@type": "Organization",
"name": "Departments of Physiology and Pharmacology, Paediatrics, and Oncology, University of Western Ontario, and Genetics and Development Division, Children's Health Research Institute, Lawson Health Research Institute, London, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Minna Woo",
"url": "https://recherchemedicale.com/author/Minna%20Woo",
"affiliation": {
"@type": "Organization",
"name": "Departments of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Dana K Andersen",
"url": "https://recherchemedicale.com/author/Dana%20K%20Andersen",
"affiliation": {
"@type": "Organization",
"name": "Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD."
}
},
{
"@type": "Person",
"name": "Guillermo Arreaza-Rubín",
"url": "https://recherchemedicale.com/author/Guillermo%20Arreaza-Rub%C3%ADn",
"affiliation": {
"@type": "Organization",
"name": "Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience.",
"datePublished": "2023-04-20",
"url": "https://recherchemedicale.com/article/37078281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/STROKEAHA.122.040743"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inpatient assessment of the neurological outcome of acute stroke patients based on the National Institute of Health Stroke Scale (NIHSS).",
"datePublished": "2022-10-05",
"url": "https://recherchemedicale.com/article/36268288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amsu.2022.104770"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reliability of the National Institutes of Health (NIH) Stroke Scale Between Emergency Room and Neurology Physicians for Initial Stroke Severity Scoring.",
"datePublished": "2023-04-14",
"url": "https://recherchemedicale.com/article/37197099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.37595"
}
},
{
"@type": "ScholarlyArticle",
"name": "Penfield and the Founding of the National Institute of Neurological Diseases and Blindness.",
"datePublished": "2022-07-08",
"url": "https://recherchemedicale.com/article/35801275",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/cjn.2022.271"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cerebral palsy pain instruments: Recommended tools for clinical research studies by the National Institute of Neurological Disorders and Stroke Cerebral Palsy Common Data Elements project.",
"datePublished": "2023-08-31",
"url": "https://recherchemedicale.com/article/37650571",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/dmcn.15743"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://recherchemedicale.com/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organismes",
"item": "https://recherchemedicale.com/mesh/D009938"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gouvernement",
"item": "https://recherchemedicale.com/mesh/D006076"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agences gouvernementale américaines",
"item": "https://recherchemedicale.com/mesh/D037041"
},
{
"@type": "ListItem",
"position": 6,
"name": "Department of Health and Human Services (USA)",
"item": "https://recherchemedicale.com/mesh/D014483"
},
{
"@type": "ListItem",
"position": 7,
"name": "Public Health Service (USA)",
"item": "https://recherchemedicale.com/mesh/D014492"
},
{
"@type": "ListItem",
"position": 8,
"name": "National Institutes of Health (USA)",
"item": "https://recherchemedicale.com/mesh/D009316"
},
{
"@type": "ListItem",
"position": 9,
"name": "National Institute of Neurological Disorders and Stroke (USA)",
"item": "https://recherchemedicale.com/mesh/D055825"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : National Institute of Neurological Disorders and Stroke (USA) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-23",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Comment diagnostiquer un AVC ?\nQuels tests pour les troubles neurologiques ?\nQuels symptômes nécessitent un diagnostic urgent ?\nComment évaluer la démence ?\nQuel rôle des antécédents médicaux dans le diagnostic ?",
"url": "https://recherchemedicale.com/mesh/D055825#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Quels sont les symptômes d'un AVC ?\nComment reconnaître la sclérose en plaques ?\nQuels signes de la maladie d'Alzheimer ?\nQuels symptômes de la maladie de Parkinson ?\nQuels symptômes de l'épilepsie ?",
"url": "https://recherchemedicale.com/mesh/D055825#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Comment prévenir un AVC ?\nQuelles mesures pour éviter la démence ?\nComment réduire le risque de sclérose en plaques ?\nQuelles stratégies pour prévenir la maladie de Parkinson ?\nComment prévenir les crises d'épilepsie ?",
"url": "https://recherchemedicale.com/mesh/D055825#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Quels traitements pour l'AVC ischémique ?\nComment traiter la sclérose en plaques ?\nQuelles options pour la maladie d'Alzheimer ?\nQuel traitement pour la maladie de Parkinson ?\nComment gérer l'épilepsie ?",
"url": "https://recherchemedicale.com/mesh/D055825#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Quelles complications après un AVC ?\nQuels risques liés à la sclérose en plaques ?\nQuelles complications de la maladie d'Alzheimer ?\nQuels effets secondaires des traitements Parkinson ?\nQuelles complications de l'épilepsie ?",
"url": "https://recherchemedicale.com/mesh/D055825#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur National Institute of Neurological Disorders and Stroke (USA)",
"description": "Quels facteurs de risque pour l'AVC ?\nQuels risques pour la sclérose en plaques ?\nQuels facteurs de risque pour la maladie d'Alzheimer ?\nQuels risques associés à la maladie de Parkinson ?\nQuels facteurs de risque pour l'épilepsie ?",
"url": "https://recherchemedicale.com/mesh/D055825#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un AVC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un AVC est diagnostiqué par un examen neurologique et des imageries cérébrales comme le CT ou l'IRM."
}
},
{
"@type": "Question",
"name": "Quels tests pour les troubles neurologiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'électroencéphalogramme (EEG) et les tests de conduction nerveuse sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic urgent ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme une faiblesse soudaine, des troubles de la parole ou des maux de tête intenses."
}
},
{
"@type": "Question",
"name": "Comment évaluer la démence ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La démence est évaluée par des tests cognitifs et des examens neurologiques complets."
}
},
{
"@type": "Question",
"name": "Quel rôle des antécédents médicaux dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux aident à identifier les risques et les causes possibles des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un AVC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une faiblesse, des troubles de la parole, et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment reconnaître la sclérose en plaques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des engourdissements, des troubles de l'équilibre et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Quels signes de la maladie d'Alzheimer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des pertes de mémoire, des difficultés de langage et des changements de comportement."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la maladie de Parkinson ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des tremblements, une rigidité musculaire et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Quels symptômes de l'épilepsie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des convulsions, des absences et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir un AVC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, le contrôle de la pression artérielle et l'arrêt du tabac."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la démence ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des activités cognitives, une alimentation équilibrée et l'exercice régulier peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de sclérose en plaques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention prouvée, mais un mode de vie sain peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour prévenir la maladie de Parkinson ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'exercice régulier et une alimentation saine peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crises d'épilepsie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prise régulière de médicaments et l'évitement des déclencheurs connus sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'AVC ischémique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des médicaments thrombolytiques et des interventions chirurgicales si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment traiter la sclérose en plaques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des médicaments immunomodulateurs et des thérapies symptomatiques."
}
},
{
"@type": "Question",
"name": "Quelles options pour la maladie d'Alzheimer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments pour améliorer la mémoire et des thérapies de soutien."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la maladie de Parkinson ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des médicaments dopaminergiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Comment gérer l'épilepsie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'épilepsie est gérée par des médicaments antiépileptiques et des interventions chirurgicales si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles complications après un AVC ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des troubles de la parole, des problèmes de mobilité et des infections."
}
},
{
"@type": "Question",
"name": "Quels risques liés à la sclérose en plaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des infections, des problèmes de mobilité et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quelles complications de la maladie d'Alzheimer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des troubles de la déglutition et des chutes."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements Parkinson ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'épilepsie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des blessures dues aux crises et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'AVC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité."
}
},
{
"@type": "Question",
"name": "Quels risques pour la sclérose en plaques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'âge, le sexe féminin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la maladie d'Alzheimer ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, des antécédents familiaux et des traumatismes crâniens."
}
},
{
"@type": "Question",
"name": "Quels risques associés à la maladie de Parkinson ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'âge, des antécédents familiaux et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'épilepsie ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents de traumatismes crâniens, des infections et des antécédents familiaux."
}
}
]
}
]
}
Departments of Physiology and Pharmacology, Paediatrics, and Oncology, University of Western Ontario, and Genetics and Development Division, Children's Health Research Institute, Lawson Health Research Institute, London, Ontario, Canada.
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD william.cefalu@nih.gov.
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
Department of Public Health Sciences, Medical University of South Carolina, Charleston (W.Z., S.D.Y., V.L.D.-M., C.N.M., R.H.M., C.R.D., C.N.C., K.H.P., J.J.E.).
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
Departments of Neurology and Rehabilitation Medicine, University of Cincinnati Neuroscience Institute, University of Cincinnati Academic Health Center, OH (J.P.B.).
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China yongjunwang@ncrcnd.org.cn zhaojz205@163.com.
National Center for Healthcare Quality Management in Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Publications dans "National Institute of Neurological Disorders and Stroke (USA)" :
From 2016 to 2021, the National Institutes of Health Stroke Trials Network funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke initiated ten multicenter ran...
Identify the association between stroke severity and the neurological outcome of an acute stroke using the National Institutes of Health stroke scale (NIHSS)....
A descriptive cross-sectional study.Place and duration of study: Northwest hospital Hayatabad Peshawar....
A cross-sectional descriptive study was done in the general plus stroke unit of the northwest hospital in Peshawar, KPK during Jan 2022 to July 2022.400 admitted patients diagnosed with acute stroke i...
In this cross-sectional descriptive study, 400 individuals ranging from 30 to 90 years of age were divided into two groups: males and females. The survey was conducted by 49% of men and 51% of women. ...
According to our findings, the NIHSS is a reliable scale for evaluating patients' neurological outcomes and determining the association between acute stroke severity and cognitive functioning (NIHSS)....
In patients with acute ischemic stroke (AIS), the National Institutes of Health Stroke Scale (NIHSS) is essential to establishing a patient's initial stroke severity. While previous research has valid...
Data was retrospectively collected from 1,946 patients being evaluated for AIS at Houston Methodist Hospital from 05/2016 - 04/2018. Triage NIHSS scores assessed by both the ER and neurology providers...
The distribution of the NIHSS score differences (ER score - neurology score) had a mean of -0.46 and a standard deviation of 2.11. The score difference between provider teams ranged ±5 points. The int...
We evaluated triage NIHSS scores performed by ER and neurology providers under matching time and treatment conditions and found excellent interrater reliability. The excellent score agreement has impo...
As conceived by Wilder Penfield the Montreal Neurological Institute (MNI) integrated neurology, neurosurgery, and allied disciplines within a single institution, where research and teaching complement...
This study describes the process of updating the cerebral palsy (CP) common data elements (CDEs), specifically identifying tools that capture the impact of chronic pain on children's functioning....
Through a partnership between the American Academy for Cerebral Palsy and Developmental Medicine and the National Institute of Neurological Disorders and Stroke (NINDS), the CP CDEs were developed as ...
Fifteen chronic pain tools met inclusion criteria, representing constructs across all components of the International Classification of Functioning, Disability and Health....
This paper describes the first condition-specific pain CDEs for a pediatric population. The proposed set of chronic pain tools complement and enhance the applicability of the existing pediatric CP CDE...
There are stark inequities in stroke incidence, prevalence, acute care, rehabilitation, risk factor control, and outcomes. To address these inequities, it is critical to engage communities in identify...
The Stroke Treatment Academic Industry Roundtable (STAIR) convened a session and workshop regarding enrollment in acute stroke trials during the STAIR XII meeting on March 22, 2023. This forum brought...
The NINDS rt-PA Stroke Study is frequently cited in support of alteplase for acute ischemic stroke within 3 h of symptom onset. Multiple post-hoc reanalyses of this trial have been published to adjust...
A risk of selection bias assessment was conducted using signaling questions from the Cochrane Risk of Bias 2 (ROB 2) tool. Four sensitivity analyses were conducted on the trial data based on the rando...
Based on criteria from the ROB 2 tool, the risk of bias arising from the randomization process was high. Sensitivity analyses found 11 of 16 unique strata deviated from the expected 1:1 allocation rat...
This risk of selection bias assessment revealed a high risk of selection bias in the NINDS rt-PA Stroke Study. Sensitivity analyses conducted based on the randomization process supported this assessme...
Even in the era of technology-guided medicine, the clinician must integrate into his daily practice a careful anamnesis and physical examination to be conducted within a close doctor-patient relations...
Cerebrovascular disease is the second most common cause of death in people more than 60 years of age. Predicting the outcome of the stroke is a great challenge for physicians. Various risk factors suc...
To assess the degree of impact of NIHSS score in comparison to the other traditional risk factors on the functional outcome and 30-day mortality by mRS in the patients with acute ischemic stroke....
Patients with acute ischemic stroke and age more than 18 years were included. Their admission NIHSS score and the 30-day mRS were analyzed. Patients were divided into two groups as survivors and non-s...
The mean age of survivors and non-survivors was 59.77 ± 10.99 and 65.58 ± 6.67 years, respectively. The NIHSS score on day 1 for non-survivors was 21.21 ± 8.21, and almost half of this score was seen ...
The NIHSS and mRS scales are simple, validated, easily applicable, and reliable tools for assessing the mortality and the functional outcome of ischemic stroke patients....